News|Articles|November 17, 2026

US Loses Measles Elimination Status as 2026 Cases Top 5400

Listen
0:00 / 0:00

Key Takeaways

  • PAHO criteria for elimination loss were met via continuous circulation of the same measles strain for ≥12 months, ending a designation held since 2000.
  • Case counts surged to 5412 in 2026, with 48 outbreaks and 10 deaths, more than doubling 2025 totals and dwarfing 2024 incidence.
SHOW MORE

The PAHO confirmed the loss after more than 12 months of continuous transmission, putting renewed focus on pharmacists' role in closing vaccination gaps.

The US has officially lost its measles elimination status, according to the Pan American Health Organization (PAHO), which announced the decision on Tuesday, November 17, ABC News reported.1 The country had held the designation since 2000, and it is lost when the same strain of the virus circulates continuously for 12 months or longer.

Epidemiologist and ABC News medical contributor John Brownstein, called the development "a historic public health setback."1

The announcement caps a record-setting year for measles cases. According to the latest CDC data, 5412 measles infections have been reported in 2026 across nearly every state, with 10 deaths reported by state health departments and 48 outbreaks identified. Drug Topics previously reported that the 2026 total had already reached its highest level since 1991, more than doubling the 2289 cases reported in all of 2025.2 In comparison, fewer than 300 cases were reported in 2024.1

The CDC said it remains committed to regaining elimination status, with Director Erica Schwartz noting the agency has invested $100 million in state and local health departments serving affected communities. HHS added that Secretary Robert F. Kennedy Jr. and Schwartz continue to recommend the MMR vaccine as the most effective way to prevent measles.1

Declining Coverage Fuels Spread

Public health experts point to falling vaccination rates as the main driver. National kindergarten MMR coverage dropped from 95.2% in the 2019-2020 school year to 92.4% in 2025-2026, below the 95% threshold for herd immunity, while kindergarten vaccine exemptions, primarily nonmedical, reached a record 4.2%.2 Containing a single measles case costs roughly $60,000 in contact tracing and isolation, pulling staff away from routine care.2,3

Policy uncertainty has added to the challenge. An August 10 executive order directed federal agencies to split combination childhood vaccines into single-disease shots, though no standalone measles, mumps, or rubella vaccines are currently licensed or produced in the US, and infectious disease experts say there is no clinical rationale for separating them.3

The Pharmacist's Role

As some of the most accessible health care providers, pharmacists are well positioned to help close immunity gaps. With vaccine-hesitant patients and parents, experts recommend motivational interviewing (asking open-ended questions, validating concerns, and requesting permission before sharing evidence) over direct myth-busting.2,3 Two MMR doses are 97% effective at preventing infection, according to the CDC, and infants younger than 12 months in outbreak areas may be eligible for earlier vaccination.1

REFERENCES
1. Benadjaoud Y. US officially loses measles elimination status, PAHO says. ABC News. November 17, 2026. Accessed November 17, 2026. https://abcnews.com/Health/us-officially-loses-measles-elimination-status-paho/story?id=138203543
2. Nowosielski B. Measles cases near 5000 in 2026 as flu season starts earlier than usual. Drug Topics. November 5, 2026. Accessed November 17, 2026. https://www.drugtopics.com/view/measles-cases-near-5000-in-2026-as-flu-season-starts-earlier-than-usual
3. Nowosielski B, Lew T, O'Shea M, Goodman J. The pharmacist's role amid measles surge, vaccine policy change. Drug Topics. September 10, 2026. Accessed November 17, 2026. https://www.drugtopics.com/view/the-pharmacist-s-role-amid-measles-surge-vaccine-policy-change

Related to this article